New research from the University of Southampton has identified how changes in the cell
membrane1 play a pivotal role in how the Hepatitis C virus
replicates3. By understanding this process, the researchers hope to investigate how to prevent the changes and potentially develop
therapeutic4 drugs to combat the Hepatitis C virus (HCV), which infects an estimated 170 million people globally.
When HCV infects a cell it uses one of its proteins, NS4B, to form a lipid-rich structure called the '
membranous5 web'. This structure contains 'reaction centres', where the virus can
replicate2 protected from the host cell's antivirus defences.
Within NS4B, the AH2 peptide plays a crucial role in
remodelling6 lipid
membranes7 to form the membranous web. However, it is not understood how AH2 causes these changes.
Using nuclear magnetic
resonance8 (NMR) spectroscopy in conjunction with
molecular9 dynamics10 (MD), Southampton researchers showed that AH2 interacts with negatively charged lipid membranes within the cell. It causes them to become more
malleable11, a property almost certainly important in reaction centre formation. When introduced into membranes with non-charged lipids, AH2 behaved differently, forming larger complexes resulting in limited
deformation12 of the membrane, consistent with a separate role in early steps of membranous web formation.
Co-author of the study Dr Phil Williamson, Lecturer in Biological Sciences, says: "Now we begin to understand at the molecular level how HCV
hijacks13 cellular14 membranes to aid its replications, we can use this information to help identify novel sites for therapeutic
intervention15 to target HCV and similar viruses."
Co-author Dr Chris McCormick, from Medicine at the University of Southampton, adds: "This gives us an important lead on how changes in lipid content in the membranous web help drive membrane remodelling. The challenge for us now is to use the same interdisciplinary approach to link these activities with other maturation events seen inside the infected cell."